Naoki Maezawa

No ORCID on file · 1 paper in corpus
diagnostic-accuracy 2023
Obstetrics & Gynecology Science ·doi:10.5468/ogs.23024

OBJECTIVE: We evaluated the usefulness of human epididymis protein 4 (HE4), a tumor marker, during and after treatment in patients with ovarian cancer (OC). METHODS: We included Japanese patients newly diagnosed with OC treated at the Nati…